We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,107 hedge funds and large institutions have $257B invested in Johnson & Johnson in 2024 Q4 according to their latest regulatory filings, with 471 funds opening new positions, 1,352 increasing their positions, 1,937 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more first-time investments, than exits

New positions opened: 471 | Existing positions closed: 177

25% more call options, than puts

Call options by funds: $2.65B | Put options by funds: $2.11B

6% more funds holding

Funds holding: 3,8844,107 (+223)

0.54% more ownership

Funds ownership: 71.49%72.03% (+0.54%)

8% less capital invested

Capital invested by funds: $278B → $257B (-$20.9B)

24% less funds holding in top 10

Funds holding in top 10: 191146 (-45)

30% less repeat investments, than reductions

Existing positions increased: 1,352 | Existing positions reduced: 1,937

Holders
4,107
Holders Change
+223
Holders Change %
+5.74%
% of All Funds
54.06%
Holding in Top 10
146
Holding in Top 10 Change
-45
Holding in Top 10 Change %
-23.56%
% of All Funds
1.92%
New
471
Increased
1,352
Reduced
1,937
Closed
177
Calls
$2.65B
Puts
$2.11B
Net Calls
+$534M
Net Calls Change
-$67.5M
Name Holding Trade Value Shares
Change
Change in
Stake
RC
426
RBO & Co
California
$30.9M +$256K +1,654 +0.8%
LCS
427
Levin Capital Strategies
New York
$30.8M +$215K +1,390 +0.7%
AWM
428
Absher Wealth Management
North Carolina
$30.8M +$3.49M +22,527 +12%
GI
429
Gradient Investments
Minnesota
$30.7M -$1.99M -12,812 -6%
KIA
430
KCM Investment Advisors
California
$30.4M -$1.82M -11,730 -5%
ZIC
431
ZWJ Investment Counsel
Georgia
$30.2M +$273K +1,760 +0.8%
DILIC
432
Dai-ichi Life Insurance Company
Japan
$30.1M +$3.6M +23,212 +13%
HWM
433
HB Wealth Management
Georgia
$30M +$536K +3,460 +2%
CTA
434
Chesley Taft & Associates
Illinois
$30M -$233K -1,505 -0.7%
OPERF
435
Oregon Public Employees Retirement Fund
Oregon
$29.9M +$58.9K +380 +0.2%
AI
436
Atria Investments
North Carolina
$29.8M +$494K +3,190 +2%
OAC
437
OMERS Administration Corp
Ontario, Canada
$29.8M +$93.9K +606 +0.3%
HIC
438
Harvey Investment Company
Kentucky
$29.7M -$76.2K -492 -0.2%
FCIM
439
Fairview Capital Investment Management
California
$29.6M -$1.79M -11,564 -5%
Pacer Advisors
440
Pacer Advisors
Pennsylvania
$29.6M -$9.49M -61,230 -23%
CIM
441
Corda Investment Management
Texas
$29.5M +$709K +4,575 +2%
MAM
442
Madison Asset Management
Wisconsin
$29.5M +$5.85M +37,732 +23%
MIA
443
Madison Investment Advisors
Wisconsin
$29.5M +$31.6M +203,767 New
NW
444
NewEdge Wealth
Pennsylvania
$29.4M +$2.4M +15,503 +8%
SI
445
Stephens Inc
Arkansas
$29.3M +$123K +793 +0.4%
ST
446
Sabal Trust
Florida
$29.2M -$679K -4,379 -2%
CFC
447
Cincinnati Financial Corp
Ohio
$29.1M
HTHT
448
Hemenway Trust Hemenway Trust
New Hampshire
$29M -$455K -2,933 -1%
GAM
449
Gotham Asset Management
New York
$28.8M -$2.87M -18,510 -9%
BCI
450
Brinker Capital Investments
Pennsylvania
$28.8M -$415K -2,675 -1%

JNJ Hedge Fund Activity: Q4 2024 in Review

4,107 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2024, worth a combined $257B — down 7.5% from $278B a quarter earlier.

Buyers outnumbered sellers: 471 funds opened new JNJ positions and 177 closed out — a net gain of 294 holders — while 1,352 added to existing stakes and 1,937 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $729M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.38B.

  • 4,107 institutional investors held Johnson & Johnson (JNJ) as of Q4 2024, up from 3,884 in Q3 2024.
  • Funds reported $257B of Johnson & Johnson stock for Q4 2024, down 7.5% quarter-over-quarter.
  • 471 funds opened new Johnson & Johnson positions in Q4 2024 and 177 closed out, a net change of +294 holders.
  • The largest Johnson & Johnson buyer in Q4 2024 was Pinnacle Associates, an estimated $729M added.
  • The largest Johnson & Johnson seller in Q4 2024 was T. Rowe Price Associates, an estimated $1.38B sold.

Based on aggregated 13F filings for Q4 2024.